SK bioscience and Hilleman Laboratories Announce Joint Development of Second-Generation Zaire Ebola Virus Vaccine Read more
Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ (metronidazole) Oral Suspension Read more
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs Read more
Ionis enters collaboration to advance next generation program targeting Lp(a) for cardiovascular disease Read more
FDA Approves Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older Read more
RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First Commercial Order Outside the U.S. Read more
European Commission Approves Gilead’s Trodelvy For Pre-Treated HR+/HER2- Metastatic Breast Cancer Read more
InSilicoTrials and Axoltis Pharma Collaborate to Advance Therapeutic Solutions for Neurological Disorders Read more
LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitis Read more
Cognizant and Gilead Extend Partnership with Five-Year Service Agreement Estimated at $800 Million Read more